CCM
CL icon

Carderock Capital Management’s Colgate-Palmolive CL Stock Holding History

Carderock Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-800
Closed -$72.7K – 82
2025
Q2 		$72.7K Buy
+800
New +$73K 0.02% 100
2023
Q2 		– Sell
-925
Closed -$69.5K – 68
2023
Q1 		$69.5K Buy
+925
New +$68.8K 0.02% 86
2022
Q1 		– Sell
-2,525
Closed -$215K – 74
2021
Q4 		$215K Hold
2,525
– – 0.05% 79
2021
Q3 		$191K Buy
+2,525
New +$200K 0.05% 75
2014
Q2 		– Sell
-108
Closed -$7K – 110
2014
Q1 		$7K Buy
+108
New +$6.81K ﹤0.01% 224

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Carderock Capital Management's CL Position: Q3 2025 in Review

Carderock Capital Management sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 800 shares — an estimated $72.7K sold.

Carderock Capital Management first reported a position in CL in Q1 2014 and held it in 5 quarters. The position peaked at $215K in Q4 2021. 1,845 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Carderock Capital Management reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Carderock Capital Management sold 800 Colgate-Palmolive shares in Q3 2025, an estimated $72.7K.
  • Carderock Capital Management first reported a position in Colgate-Palmolive in Q1 2014 and held it in 5 quarters.
  • Carderock Capital Management's Colgate-Palmolive position peaked at $215K in Q4 2021.
  • 1,845 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Carderock Capital Management's 13F filing for Q3 2025, filed 17 Oct 2025.